Adam is an Anatomic Pathology resident at MGH and began working in the lab in 2020. His clinical and research interests involve the integration of molecular techniques and findings in surgical pathology to discover biological markers and targetable pathways in tumors, particularly those of the head and neck. ORCID: https://orcid.org/0000-0002-4742-8165 Twitter: @adamsfisch
Computational Scientist with a background in computer engineering working on the characterization of transposable elements in healthy cells and cancer. Interested in robust statistical approaches to analyze data from single-cell experiments. ORCID: https://orcid.org/0000-0002-8889-658X LinkedIn: https://www.linkedin.com/in/eugeniomattei/ @eugmattei
Interests: Epigenetic circuits in immune cells; High dimensional profiling in tumor microenvironments Zeyu Chen did his undergraduate at Peking University in Beijing, China, studying stem cell genetic engineering in Dr. Hongkui Deng’s lab. He then worked as a research assistant in Dr. Richard Flavell’s lab at Yale for one year, and did his Ph.D. at University … Continued
Computational and molecular biologist, interested in multidisciplinary approaches to understand gene regulation in healthy cells and during cancer development. Orcid: 0000-0002-6059-0116 https://www.linkedin.com/in/elena-torlai-triglia/ https://elenatt.github.io/cv/
Chadi El Farran is a Lebanese national who joined the lab as a Research Fellow. Chadi is interested in deciphering the cell-cell communication patterns that define the fate and function of these cells. He is also keen on studying the epigenetic and transcriptomic changes which are associated with diseases.
Carmen is a Research Fellow originally from Belgium. She is intrigued by how nuclear shape contributes to nuclear function and how cells have evolved to regulate the nuclear architecture to define identity in normal physiology and disease.
Ty is a Clinical Pathology resident at MGH and joined the lab as a research fellow in 2019. He studies the tumor microenvironment in glioblastoma to discover novel ways to target tumor cells. He is currently profiling cellular states of both normal and neoplastic cells in glioblastoma tumors to identify ways to harness the immune … Continued
